Gabelli upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a hold rating to a buy rating in a report released on Wednesday, May 8th, Briefing.com Automated Import reports. Gabelli currently has $42.00 target price on the stock. The analysts noted that the move was a valuation call.
A number of other research firms have also weighed in on PAHC. BidaskClub upgraded shares of Phibro Animal Health from a hold rating to a buy rating in a research note on Tuesday, May 7th. Zacks Investment Research upgraded shares of Phibro Animal Health from a sell rating to a hold rating in a research note on Monday, April 29th. Finally, ValuEngine raised shares of Phibro Animal Health from a sell rating to a hold rating in a report on Thursday, March 21st. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of $43.50.
Shares of PAHC stock opened at $29.58 on Wednesday. The company has a quick ratio of 1.98, a current ratio of 3.41 and a debt-to-equity ratio of 1.48. Phibro Animal Health has a 12-month low of $28.26 and a 12-month high of $54.62. The company has a market cap of $1.21 billion, a PE ratio of 17.00, a P/E/G ratio of 4.43 and a beta of 0.63.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 5th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.62%. The ex-dividend date of this dividend is Tuesday, June 4th. Phibro Animal Health’s payout ratio is 27.59%.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC lifted its holdings in shares of Phibro Animal Health by 82.7% during the 1st quarter. FMR LLC now owns 337,652 shares of the company’s stock worth $11,143,000 after acquiring an additional 152,853 shares during the last quarter. Zebra Capital Management LLC lifted its stake in Phibro Animal Health by 9.4% in the first quarter. Zebra Capital Management LLC now owns 7,059 shares of the company’s stock worth $233,000 after purchasing an additional 604 shares during the last quarter. Morgan Stanley lifted its stake in Phibro Animal Health by 83.7% in the first quarter. Morgan Stanley now owns 226,799 shares of the company’s stock worth $7,485,000 after purchasing an additional 103,345 shares during the last quarter. Man Group plc lifted its stake in Phibro Animal Health by 12.2% in the first quarter. Man Group plc now owns 177,158 shares of the company’s stock worth $5,846,000 after purchasing an additional 19,200 shares during the last quarter. Finally, Advisors Asset Management Inc. lifted its stake in Phibro Animal Health by 136.0% in the first quarter. Advisors Asset Management Inc. now owns 5,984 shares of the company’s stock worth $197,000 after purchasing an additional 3,448 shares during the last quarter. 50.25% of the stock is owned by institutional investors.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Recommended Story: Fundamental Analysis
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.